CatalYm GmbH
Industry / private company
Location:
Planegg-Martinsried,
Germany (DE)
ISNI: -
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment (2023)
Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, et al.
Journal article
TUMOR-DERIVED GDF-15 PREVENTS THERAPY SUCCESS OF CHECKPOINT INHIBITORS BY BLOCKING T-LYMPHOCYTE RECRUITMENT (2021)
Haake M, Schaefer T, Haack B, Vashist N, Genssler S, Harter P, Martens A, et al.
Conference contribution